TrialsgrambetaRCTs are beautiful

ESC Congress 2026

El congreso ha terminado: cada ensayo muestra aquí su resultado en cuanto está en el registro.

Fechas
28–31 de agosto de 2026
Lugar
Munich · Messe München
Estado
Finalizado
Horarios
Hora de la sede · BerlinDías del programa · Munich

Hot Line

Presentaciones
58
Con resultado
58
En el registro
0
Resultado pendiente
0

viernes, 28 de agosto

2026 ESC Guidelines and Document overview

08:15-09:45 CESTMain Auditorium (Hall B3)Programa de la sesión

Hot Line 1

11:00-12:18 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 11:00CESTCARDIO-TTRansformEstudio claveResultado del congresoIn 1,432 patients with transthyretin amyloid cardiomyopathy, eplontersen did not reduce cardiovascular death or recurrent cardiovascular events at 140 weeks compared with placebo.IRR 0,89IC del 95% 0,73-1,09
  • 11:15CESTSINGLE-AFResultado del congresoIn 1,803 patients with atrial fibrillation at intermediate stroke risk, a direct oral anticoagulant reduced the net composite of stroke, embolism, major bleeding and death at 2 years compared with no anticoagulation.HR 0,31IC del 95% 0,10-0,94
  • 11:30CESTPOET-IIResultado del congresoIn 508 patients with left-sided infective endocarditis, a tailored 2–4-week antibiotic course was non-inferior to the standard 4–6-week course for death, unplanned cardiac surgery, relapse or embolisation at 6 months.8,2% vs. 10,7%
  • 11:45CESTACACIA-HCMResultado del congresoIn 517 patients with symptomatic non-obstructive hypertrophic cardiomyopathy, aficamten improved KCCQ clinical summary score and peak oxygen uptake at 36 weeks compared with placebo.
  • 12:03CESTCMR GUIDEResultado del congresoIn 353 patients with LVEF 36–50 % and scar on cardiac MRI, a primary-prevention ICD did not reduce sudden cardiac death or haemodynamically significant ventricular arrhythmia compared with an implantable loop recorder.HR 0,76IC del 95% 0,37-1,58

2026 ESC Guidelines for the Management of Heart Failure

13:45-15:00 CESTMain Auditorium (Hall B3)Programa de la sesión

sábado, 29 de agosto

Hot Line 2

08:15-09:45 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 08:15CESTSTAREEEstudio claveResultado del congresoIn 9,971 healthy adults aged 70 years or over, atorvastatin 40 mg improved one of two co-primary outcomes disability-free survival and major cardiovascular events compared with placebo.HR 0,70IC del 95% 0,61-0,82
  • 08:30CESTAMUNDSENResultado del congresoIn 2,161 patients with acute myocardial infarction undergoing PCI, evolocumab started before PCI increased achievement of an LDL-C reduction of ≥50 % to below 1.4 mmol/L at 12 months compared with standard lipid-lowering care.OR 5,54IC del 95% 4,50-6,82
  • 08:45CESTTRANQUILITYResultado del congresoIn 143 patients with chronic kidney disease and raised hs-CRP, pacibekitug, an IL-6 antibody reduced hs-CRP through day 90 compared with placebo.
  • 09:00CESTREACTResultado del congresoIn 16,808 adults aged 18–70 years without known cardiovascular disease, whole-body imaging for atherosclerosis was studied for the age- and sex-specific prevalence of silent atherosclerosis.
  • 09:15CESTENRICH-AFResultado del congresoIn 948 patients with atrial fibrillation and a previous intracranial haemorrhage, edoxaban did not reduce stroke or systemic embolism, and major haemorrhage compared with no anticoagulation.HR 0,88IC del 95% 0,61-1,26
  • 09:30CESTDAN-RSVResultado del congresoIn 511,535 adults aged 18 years or over in Denmark and Galicia, a single dose of RSVpreF vaccine reduced hospitalisation for RSV-related respiratory disease compared with no vaccine.

Hot Line 3

11:00-12:15 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 11:00CESTLIBREXIA ACSResultado del congresoIn 14,194 patients with a recent acute coronary syndrome, milvexian added to antiplatelet therapy did not reduce cardiovascular death, myocardial infarction or ischaemic stroke compared with placebo.HR 1,05IC del 95% 0,91-1,21
  • 11:15CESTPREMIUMResultado del congresoIn 2,216 patients with STEMI undergoing primary PCI, aspirin-free prasugrel monotherapy was not non-inferior to 12 months of dual antiplatelet therapy for death, myocardial infarction or stroke at 12 months.HR 1,34IC del 95% 1,02-1,75
  • 11:30CESTSWITCH SWEDEHEARTResultado del congresoIn 17,095 patients with an acute coronary syndrome, prasugrel as the default P2Y12 inhibitor did not reduce death, myocardial infarction or stroke at 1 year compared with ticagrelor.OR 0,90IC del 95% 0,77-1,06
  • 11:45CESTA-CLOSEResultado del congresoIn 3,203 high-risk patients after 12 months of DAPT following PCI, clopidogrel monotherapy was non-inferior to extended dual antiplatelet therapy for net adverse clinical events at 24 months.5,0% vs. 5,1%
  • 12:00CESTEPIDAURUSResultado del congresoIn 602 patients with atrial fibrillation and ACS after PCI, one month of a potent P2Y12 inhibitor plus a NOAC did not reduce major ischaemic events at 6 weeks compared with clopidogrel plus a NOAC.HR 3,54IC del 95% 1,15-10,85

2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease

13:45-15:00 CESTMain Auditorium (Hall B3)Programa de la sesión

Hot Line 4

16:15-17:15 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 16:15CESTPRESC1SE-MIResultado del congresoIn 67,624 emergency presentations with suspected myocardial infarction, the ESC 0/1-hour troponin algorithm was non-inferior to the 0/3-hour algorithm for death or type 1 myocardial infarction at 30 days, and length of stay.OR 0,93IC del 95% 0,77-1,13
  • 16:25CEST0/1-hour IPDMAResultado del congresoIn patients with suspected myocardial infarction in pooled pathway studies, the ESC 0/1-hour troponin algorithm did not improve diagnostic safety and efficacy compared with standard-care pathways.
  • 16:45CESTAIR-STEMIResultado del congresoIn 1,823 patients with STEMI and multivessel disease, angiography-derived FFR-guided non-culprit PCI reduced death, stroke, reinfarction or ischaemia-driven revascularisation compared with angiography-guided PCI.HR 0,62IC del 95% 0,47-0,83
  • 17:00CESTTARGET-CTCAResultado del congresoIn 3,170 patients with suspected ACS, infarction ruled out and an intermediate troponin, outpatient CT coronary angiography did not reduce myocardial infarction or cardiac death compared with standard care.HR 0,95IC del 95% 0,73-1,23

Hot Line 5

17:30-18:35 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 17:30CESTEMAIL-HFResultado del congresoIn 5,996 patients with heart failure not on an SGLT2 inhibitor, a digital letter inviting specialist review increased initiation of an SGLT2 inhibitor within 6 months compared with usual care.18,6% vs. 8,2%
  • 17:45CESTRemote Exercise SWEDEHEARTResultado del congresoIn 3,112 patients after myocardial infarction referred to cardiac rehabilitation, a choice of video-delivered remote exercise did not increase the number of supervised sessions attended compared with centre-based exercise only.13,8% vs. 13,6%
  • 18:00CESTADHERE-ASCVDResultado del congresoIn 20,604 statin-non-adherent patients with cardiovascular disease or diabetes, adaptive digital outreach was compared with usual care on a statin refill within 14 days.RR 1,2IC del 95% 1,1-1,3
  • 18:15CESTVIRTUESResultado del congresoIn 1,963 patients with an ICD or pacemaker, remote-only device management via an e-health platform was non-inferior to scheduled in-clinic follow-up for major adverse cardiac events at 18 months.

domingo, 30 de agosto

Hot Line 6

08:15-09:50 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 08:15CESTH-HeFTResultado del congresoIn 592 patients with HFrEF on guideline-directed therapy, hydralazine–isosorbide dinitrate did not reduce death or worsening heart failure compared with placebo.HR 0,90IC del 95% 0,67-1,21
  • 08:25CESTH-ISDN meta-analysisResultado del congresoIn patients with HFrEF in randomised trials of hydralazine–isosorbide dinitrate, hydralazine–isosorbide dinitrate reduced clinical outcomes compared with control.
  • 08:43CESTMet-HeFTResultado del congresoIn 940 patients with HFrEF and diabetes or insulin resistance, metformin did not reduce death, worsening heart failure, myocardial infarction or stroke compared with placebo.HR 1,10IC del 95% 0,84-1,42
  • 08:53CESTMet-HeFT meta-analysisResultado del congresoIn patients with heart failure or ischaemic heart disease in studies of metformin, metformin did not reduce clinical outcomes compared with no metformin.
  • 09:09CESTLUMINARAResultado del congresoIn 375 patients with chronic heart failure, AZD5462, an oral relaxin agonist improved the change in LV end-systolic volume index or systemic vascular resistance at 24 weeks compared with placebo.
  • 09:24CESTPADN-PH-LHDResultado del congresoIn 264 patients with pulmonary hypertension due to heart failure, pulmonary artery denervation reduced clinical worsening compared with medical therapy alone.HR 0,49IC del 95% 0,30-0,82
  • 09:37CESTTIME-HFResultado del congresoIn 1,507 patients with HFrEF at 22 hospitals in India, nurse-led, app-supported collaborative care increased days alive and out of hospital over 2 years compared with usual care.OR 1,78IC del 95% 1,42-2,23

Hot Line 7

11:00-12:15 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 11:00CESTPOPular ACE TAVIResultado del congresoIn 966 patients undergoing transfemoral TAVI, routine protamine after the procedure reduced death or bleeding at 30 days compared with selective protamine.
  • 11:15CESTTAVI PCIResultado del congresoIn 986 patients with severe aortic stenosis and coronary disease, PCI after TAVI was non-inferior to PCI before TAVI for death, myocardial infarction, revascularisation, rehospitalisation or major bleeding at 1 year.22,2% vs. 24,2%
  • 11:30CESTTRIC-I-HFEstudio claveResultado del congresoIn 360 patients with severe tricuspid regurgitation and right heart failure, transcatheter tricuspid intervention reduced death, heart-failure hospitalisation and quality of life at 12 months compared with medical therapy alone.WR 2,42IC del 95% 1,76-3,33
  • 11:45CESTACASA-TAVIResultado del congresoIn 360 patients after TAVI without an indication for anticoagulation, 12 months of a factor Xa inhibitor reduced leaflet thrombosis on CT and a safety composite at 12 months compared with aspirin.RR 0,55IC del 95% 0,37-0,82
  • 11:55CESTNOTION-4Resultado del congresoIn 352 patients after TAVI without an indication for anticoagulation, 3 months of a DOAC, then antiplatelet therapy did not reduce leaflet thrombosis on CT at 1 year compared with antiplatelet therapy alone.28,3% vs. 32,2%

5th Universal Definition of Myocardial Infarction (ESC, ACC, AHA, and WHF)

13:45-15:00 CESTMain Auditorium (Hall B3)Programa de la sesión

Hot Line 8

16:15-17:15 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 16:15CESTAFFIRMOResultado del congresoIn 1,260 older patients with atrial fibrillation and multimorbidity, app-supported integrated care on the ABC pathway did not reduce unplanned hospitalisation at 12 months compared with usual care.OR 0,95IC del 95% 0,61-1,49
  • 16:30CESTPVI-SHAM-AFEstudio claveResultado del congresoIn 262 patients with symptomatic atrial fibrillation, pulmonary vein isolation did not improve AF-specific quality of life at 6 months compared with a sham procedure.
  • 16:45CESTNEXAFResultado del congresoIn 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.3,9% vs. 7,1%
  • 17:00CESTIDEAL-AFResultado del congresoIn 209 patients with persistent atrial fibrillation and low-voltage areas, pulmonary vein isolation plus individualised low-voltage ablation increased freedom from atrial arrhythmia at 12 months compared with pulmonary vein isolation alone.OR 3,50IC del 95% 1,98-6,20

Hot Line 9

17:30-18:30 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 17:30CESTSHASTA-3/4Resultado del congresoIn 757 patients with severe hypertriglyceridaemia, plozasiran every 3 months reduced the change in fasting triglycerides at 12 months compared with placebo.
  • 17:45CESTCRHCPEstudio claveResultado del congresoIn 33,995 rural Chinese adults with hypertension, village-doctor-led intensive blood-pressure control reduced all-cause dementia compared with usual care.RR 0,85IC del 95% 0,78-0,91
  • 18:00CESTBPLTTC IPD meta-analysisEstudio claveResultado del congresoIn 357,440 participants in 51 randomised blood-pressure trials, blood-pressure-lowering treatment reduced major cardiovascular events across the full spectrum of predicted risk compared with placebo or less intensive treatment.
  • 18:15CESTECLIPSE-CKDResultado del congresoIn 640 adults with hypertension and stage G2–G3a chronic kidney disease, a potassium-enriched salt substitute reduced systolic blood pressure at 3 months compared with regular salt.

lunes, 31 de agosto

Hot Line 10

08:15-09:30 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 08:15CESTASPIREDEstudio claveResultado del congresoIn 2,233 emergency patients with unexplained syncope, immediate 14-day patch ECG monitoring did not reduce self-reported syncope episodes at 1 year compared with standard care.
  • 08:30CESTDANISH-CRTEstudio claveResultado del congresoIn 1,000 patients with heart failure and bundle branch block receiving CRT, electrically targeted LV lead placement did not reduce death or unplanned heart-failure hospitalisation compared with conventional lead placement.HR 1,10IC del 95% 0,86-1,39
  • 08:40CESTSyncAV PMTResultado del congresoIn 1,288 CRT recipients with left bundle branch block, dynamic AV-delay optimisation did not reduce the reduction in LV end-systolic volume at 12 months compared with a fixed AV delay.
  • 09:00CESTSyncope-StopperResultado del congresoIn 200 older adults with high-risk unexplained syncope, upfront pacemaker implantation reduced cardiovascular death, recurrent syncope, bradycardia or device complications at 12 months compared with standard monitoring.HR 0,49IC del 95% 0,27-0,87
  • 09:15CESTHIS Alternative IIResultado del congresoIn 148 patients with HFrEF and left bundle branch block, conduction-system pacing was non-inferior to biventricular pacing for the change in LV end-systolic volume at 6 months.

2026 ESC Guidelines on Cardiac Rehabilitation

11:15-12:15 CESTMain Auditorium (Hall B3)Programa de la sesión

Hot Line 11

13:00-14:00 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 13:00CESTEVAOLDResultado del congresoIn 587 patients aged 80 years or over with NSTEMI, a selective invasive strategy guided by stress imaging was not non-inferior to routine invasive management for death, myocardial infarction or stroke at 12 months.HR 1,22IC del 95% 0,86-1,72
  • 13:15CESTISOLEDSResultado del congresoIn 664 patients undergoing PCI of a distal left main bifurcation, OCT guidance was non-inferior to IVUS guidance for target lesion failure at 12 months.HR 0,90IC del 95% 0,59-1,36
  • 13:30CESTCorCalResultado del congresoIn 5,772 statin-naïve adults in primary prevention, coronary calcium score-guided statin therapy was not non-inferior to risk score-guided statin therapy for major adverse cardiovascular events.HR 0,99IC del 95% 0,71-1,38
  • 13:45CESTCoCAPResultado del congresoIn 360 patients after CABG for an acute coronary syndrome, dual antiplatelet therapy with ticagrelor was compared with aspirin alone on graft patency on CT angiography at 12–36 months.83,3% vs. 81,6%

Hot Line 12

14:15-15:15 CESTMain Auditorium (Hall B3)Programa de la sesión

  • 14:15CESTDISCOResultado del congresoIn 1,003 comatose survivors of cardiac arrest without ST-elevation, immediate coronary angiography did not improve survival at 30 days compared with delayed, selective angiography.HR 0,95IC del 95% 0,74-1,21
  • 14:23CESTOHCA-CAG meta-analysisResultado del congresoIn patients resuscitated from cardiac arrest without ST-elevation in randomised trials of angiography timing, early coronary angiography did not improve clinical outcomes compared with delayed or selective angiography.
  • 14:36CESTHeartRunnerResultado del congresoIn 2,114 out-of-hospital cardiac arrests, smartphone activation of citizen responders did not improve survival at 30 days compared with standard EMS response.
  • 14:49CESTPRAGUE-26Estudio claveResultado del congresoIn 558 patients with intermediate–high-risk pulmonary embolism, catheter-directed thrombolysis reduced death, recurrent embolism or decompensation at 7 days compared with anticoagulation alone.RR 0,10IC del 95% 0,02-0,44
  • 15:02CESTLAACS-2Resultado del congresoIn 1,500 adults undergoing open-heart surgery, concomitant surgical left atrial appendage closure did not reduce stroke or TIA over 2 years compared with leaving the appendage open.HR 0,85IC del 95% 0,53-1,37